Clinical Evidence and Research Findings
Development and Initial Clinical Trials
Sildenafil was originally developed by Pfizer researchers in the 1980s as a potential treatment for cardiovascular conditions. During early clinical trials, researchers discovered its remarkable effects on erectile function, leading to extensive studies specifically focused on erectile dysfunction treatment. The pivotal trials involved thousands of men across multiple countries, establishing the foundation for regulatory approval.
Mechanism of Action Research
Clinical studies have thoroughly documented how sildenafil works as a phosphodiesterase type 5 (PDE5) inhibitor. Research shows it selectively blocks the PDE5 enzyme, which typically breaks down cyclic guanosine monophosphate (cGMP). By inhibiting this enzyme, sildenafil allows cGMP levels to remain elevated, promoting smooth muscle relaxation and increased blood flow to penile tissue during sexual arousal.
Efficacy Studies and Success Rates
Large-scale clinical trials consistently demonstrate sildenafil's effectiveness across diverse patient populations. Studies typically measure success using the International Index of Erectile Function (IIEF), with research showing significant improvements in erectile function scores compared to placebo groups. Success rates vary depending on the underlying cause of erectile dysfunction, patient age, and concurrent medical conditions.
Dosing Research and Optimisation
Clinical research has established optimal dosing protocols for sildenafil, with studies comparing 25mg, 50mg, and 100mg doses. Research indicates that 50mg serves as an effective starting dose for most patients, with dose adjustments made based on individual response and tolerability. Studies show that taking sildenafil on an empty stomach may improve onset time, whilst fatty meals can delay absorption.
Safety Profile and Adverse Events
Extensive safety data from clinical trials and post-marketing surveillance demonstrates sildenafil's generally well-tolerated profile when used appropriately. Common side effects identified in research include headache, facial flushing, and nasal congestion, typically mild and temporary. Serious adverse events are rare but have been documented, particularly in patients with underlying cardiovascular conditions.
Contraindication Research
Clinical studies have identified important contraindications, particularly the dangerous interaction between sildenafil and nitrate medications. Research demonstrates that this combination can cause severe hypotension, leading to strict prescribing guidelines. Studies also established contraindications for patients with severe cardiovascular disease, recent stroke, or certain eye conditions.
Long-term Studies and Ongoing Research
Long-term follow-up studies continue to monitor sildenafil's effects over extended periods, providing valuable data on sustained efficacy and safety. Current research areas include optimal timing strategies, combination therapies, and identifying patient subgroups who may benefit from specific dosing approaches. At EverydayMeds, patients can choose between sildenafil (generic) or Viagra (branded) following comprehensive clinical assessment by our qualified prescribers.
